Skip to search formSkip to main contentSkip to account menu

TAK 456

Known as: 1-(2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl)-3-(4-(1H-1-tetrazolyl)phenyl)-2-imidazolidinone, TAK-456 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
ABSTRACT TAK-456 is a novel oral triazole compound with potent and broad-spectrum in vitro antifungal activity and strong in vivo… 
2002
2002
ABSTRACT TAK-457 is an injectable prodrug of TAK-456, which is a novel oral triazole compound with potent antifungal activity… 
2001
2000
2000
New routes for the synthesis of the optically active antifungal triazoles 1-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3… 
Review
2000
Review
2000
The 40th ICAAC was the usual great event with around 15,000 participants and numerous parallel sessions of both oral and poster…